The share of FDA/EMA approved drugs studied in international clinical trials placed partially in Russia has reached 65% in 2013. Russian drug development market is also growing rapidly.
Lenpharma is dedicated to providing quality consulting services and taking the role of a strategic guide to your CRO, Pharmaceutical or Biotech company, ensuring smooth and successful entry to the emerging Russian market.
We are a team of professionals with many years of experience in this challenging industry and a sharp focus on the following services:
- Regulatory clinical study approval, import/export licenses
- Medical Affairs in Russia and Eastern Europe
- QA & QC in Russia & internationally
- Trainings ICH GCP, site auditing, SOP
- Investigators’ Meeting organization in Russia
- Storage of laboratory kits, equipment & study related materials